Home - Products - Others - Other Targets - 1-phenyl-3,4-dihydroisochinoline

1-phenyl-3,4-dihydroisochinoline

CAS No. 52250-50-7

1-phenyl-3,4-dihydroisochinoline ( 3,4-Dihydro-1-phenylisoquinoline )

Catalog No. M28613 CAS No. 52250-50-7

1-phenyl-3,4-dihydroisochinoline is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-phenyl-3,4-dihydroisochinoline
  • Note
    Research use only, not for human use.
  • Brief Description
    1-phenyl-3,4-dihydroisochinoline is a chemical compound.
  • Description
    1-phenyl-3,4-dihydroisochinoline is a chemical compound.
  • Synonyms
    3,4-Dihydro-1-phenylisoquinoline
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PDGFRβ;PDGFR2;PDGFR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    52250-50-7
  • Formula Weight
    207.3
  • Molecular Formula
    C15H13N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1Cc2ccccc2C(=N1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sun L, et al. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem. 1999 Dec 16;42(25):5120-30.
molnova catalog
related products
  • Chrysin 6-C-arabinos...

    Chrysin 6-C-arabinoside 8-C-glucoside and chrysin-6-C-glucosyl-8-C-arabinoside are α±-glucosidase inhibitors, α±-glucosidase inhibitors are widely used in the treatment of type 2 diabetes.

  • dCeMM3?

    2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide is compound used for high-throughput Screening assay.

  • L-Nabe

    L-Nabe is a effective irreversible endothelium dependent relaxation inhibitor.